SEC Form 4 · accession 0001213900-26-091823
Zentalis Pharmaceuticals, Inc. · ZNTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
WALTERS GROUP
10% Owner
William Thurman Walters
10% Owner
Susan Berkley Walters
10% Owner
Period of report
Aug 14, 2026
Accepted (ET)
Aug 19, 2026 · 6:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001725160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 14, 2026 | P | 4,335,000 | $3.50 | A | 17,844,973 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.